Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cells

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 529-534

  Akuffo, Hannah ^a   Alexis, A ^a   Eidsmo, L ^a   Saed, A ^a   Nylen S ^a   Maasho, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cytokines; IL 10; IL 12; Leishmania; Natural killer cells; Regulation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOREGULATION; INFECTION RESISTANCE; INTERFERON PRODUCTION; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, PROTOZOAN; BLOOD DONORS; CELL DIVISION; CELLS, CULTURED; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; KILLER CELLS, NATURAL; LEISHMANIA; RECOMBINANT PROTEINS;

EID: 0032765220     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00994.x     Document Type: Article

References (36)

1. 2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. J Immunol 1989; 143:3020-4.
2. 2 Sadick MD, Heinzel FP, Holaday BJ et al. Cure of murine Leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 1990; 17:115-27.
3. 3 Scott P, Caspar P, Sher A. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J Immunol 1990; 144:1075-9.
4. 4 Bogdan C, Schroppel K, Lohoff M et al. Tumor necrosis factor-α in combination with interferon gamma but not with interleukin 4 activated murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol 1990; 20:1131-5.
5. 5 Hatzigeorgiou DE, He S, Sobel J et al. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J Immunol 1993; 151:3682-92.
6. 6 Heinzel EP, Schoenhhaut DS, Rerko RM et al. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993; 177:1505-9.
7. 7 Sypek JP, Chung CL, Mayor SE et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993; 177:1797-802.
8. 8 Scharton-Kersten T, Afonso LC, Wysocka M et al. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol 1995; 154:5320-30.
9. 9 Afonso LC, Scharton TM, Vieira LQ et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994; 263:235-7.
10. 10 Gurnathan S, Sacks DL, Brown DR et al. Vaccination with DNA encoding the immunodominent LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Immunol 1997; 186:1137-47.
11. 11 Scharton T, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178:567-77.
12. 12 Trinchieri G, Wysocka M, D'Andrea A et al. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 1992; 4:355-68.
13. 13 Kubin M, Chow JM, Trinchieri G. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 1994; 83:1847-55.
14. 14 Wenner C, Guler M, Macatonia S et al. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol 1996; 156:1442-7.
15. 15 Finkelman F, Madden K, Cheever A et al. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med 1994; 179:1563-72.
16. + T cell clones from HIV-infected patients. J Clin Invest 1994; 96:1677-82.
17. 17 D'Andrea A, Aste AM, Valiante NM et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178:1041-8.
18. 18 Akuffo H, Maasho K, Howe R. Natural and acquired resistance to Leishmania: cellular activation of Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of NK cells. Clin Exp Immunol 1993; 94:516-21.
19. 19 De Yssel HWMR, Roncarolo MG et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992; 149:2378-84.
20. 20 Mehrotra PT, Donnelly RP, Wong S et al. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol 1998; 160:2637-44.
21. 21 Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science 1993; 260:496-7.
22. 22 Bøyum A. Separation of lymphocytes from blood and bone marrow. Scand J Clin Lab Invest 1969; 21 (Suppl.):77-89.
23. 23 Naume B, Nonstad U, Steinkjer B et al. Immunomagnetic isolation of NK and LAK cells. J Immunol Methods 1991; 136:1-9.
24. 24 Maasho K, Akuffo HO. Cells from healthy non-exposed individuals produce cytokines to selected fractions of Leishmania promastigotes. Scand J Immunol 1992; 36:179-84.
25. 25 Akuffo HO, Fehniger TE, Britton S. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. J Immunol 1988; 141:2461-6.
26. 26 Akuffo HO, Britton SFF. Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans. Clin Exp Immunol 1992; 87:58-64.
27. 27 Maasho K, Sanchez F, Schurr E et al. Indication of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect Immun 1998; 66:2698-704.
28. 28 D'Orazio JA, Stein-Streilein J. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T-lymphocytes. Clin Exp Immunol 1996; 104:366-73.
29. 29 Trinchieri G, Kubin M, Bellone G et al. Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity. J Cell Biochem 1993; 53:301-8.
30. 30 de Waal Malefyt R, Abrams J, Bennett B et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
31. 31 Fiorentino DF, Zlotnik A, Vieira P et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-51.
32. 32 de Spits H, WMR. Functional characterization of human IL-10. Int Arch Allergy Immunol 1992; 99:8-15.
33. 33 Carson WE, Lindeman MJ, Baiocchi R et al. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 1995; 85:3577-85.
34. + T lymphocytes. J Immunol 1995; 155:111-7.
35. 35 Jeannin P, Delneste Y, Seveso M et al. IL-12 synergizes with IL-12 and other stimuli in inducing IL-10 production by human T cells. J Immunol 1996; 156:3159-65.
36. +4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J Exp Med 1996; 183:2559-69.